Condition
Human Gut Microbiota
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Unknown1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02653001Not ApplicableEnrolling By InvitationPrimary
The QIB Colon Model
NCT01414010Not ApplicableCompletedPrimary
Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota
NCT03080532UnknownPrimary
Diet Interactions With Human Gut Microbiota. The Potential Role of Mediterranean Diet Adherence. DIAGRAM, a Pilot Study
NCT02291328Not ApplicableCompletedPrimary
Effects of Brassica on Human Gut Lactobacilli
Showing all 4 trials